Oesophageal Squamous Cell Carcinoma
Oncology·MeSH: Esophageal Squamous Cell Carcinoma
2 drugs in development·2 companies·2 clinical trials
Drug Pipeline by Phase
Phase 3(1)
| Drug | Company |
|---|---|
| I-DXd | Merck & Co., Inc. (MRK) |
Phase 1/Phase 2(1)
| Drug | Company |
|---|---|
| cetuximab | Sanofi (SNY) |
Compare drugs
Frequently asked questions
How many drugs are in development for Oesophageal Squamous Cell Carcinoma?
BioSniper tracks 2 drugs in development for Oesophageal Squamous Cell Carcinoma across 2 companies.
How many clinical trials target Oesophageal Squamous Cell Carcinoma?
There are 2 clinical trials targeting Oesophageal Squamous Cell Carcinoma tracked by BioSniper.
Deep-dive into Oesophageal Squamous Cell Carcinoma
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis